BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18723471)

  • 1. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
    Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
    Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions.
    Semple RK; Topaloglu AK
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):427-35. PubMed ID: 19719764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallmann syndrome in women: from genes to diagnosis and treatment.
    Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
    Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
    Kim SH; Hu Y; Cadman S; Bouloux P
    J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
    Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
    Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
    Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome.
    Jap TS; Chiu CY; Lirng JF; Won GS
    J Endocrinol Invest; 2011 Jan; 34(1):53-9. PubMed ID: 20530987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
    PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallmann syndrome.
    Dodé C; Hardelin JP
    Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
    Brioude F; Bouvattier CE; Lombès M
    Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
    Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
    Sarfati J; Dodé C; Young J
    Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
    Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C
    Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
    Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical genetics of Kallmann syndrome.
    Dodé C; Hardelin JP
    Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.